Home LiteratureArticle Details
PMID: 10206830 Published · ppublish English Comment Letter

Pravastatin and coronary heart disease.

The New England journal of medicine ·Vol. 340 ·No. 14 ·1999-04-08 ·Pages 1115-6; author reply 1116-7

Meyer FP

Abstract

暂无摘要

MeSH Terms
Anticholesteremic Agents/therapeutic use Cardiovascular Diseases/prevention & control Coronary Disease/drug therapy,mortality Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use Pravastatin/therapeutic use Treatment Outcome
Chemicals
Anticholesteremic Agents Hydroxymethylglutaryl-CoA Reductase Inhibitors Pravastatin
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Meyer F P
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
0028-4793
DOI
10.1056/NEJM199904083401413
Published
1999-04-08
Pages
1115-6; author reply 1116-7
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Corrections
CommentOn
PMID: 9841303
External Links
PubMed source DOI: 10.1056/NEJM199904083401413 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2